Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression

Nature Communications

Volumn 8, Issue , 2017, Pages

  Huang, Chongbiao ^a   Li, Na ^a   Li, Zengxun ^a   Chang, Antao ^b   Chen, Yanan ^b   Zhao, Tiansuo ^a   Li, Yang ^a   Wang, Xiuchao ^a   Zhang, Wei ^c   Wang, Zhimin ^c   Luo, Lin ^c   Shi, Jingjing ^a   Yang, Shengyu ^d   Ren, He ^a   Hao, Jihui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

^c Tianjin Hepingqu Gynaechology and Obstetrics Hospital   (China)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLYCOPROTEIN GP 130; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 35; STAT1 PROTEIN; ICAM1 PROTEIN, HUMAN; ICAM1 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN; INTERLEUKIN-35, MOUSE;

ADHESION; CANCER; CELLS AND CELL COMPONENTS; GENE; GENE EXPRESSION; GENETIC ANALYSIS; PROTEIN; TUMOR;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL LINE; CANCER PROGNOSIS; CANCER TISSUE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; CELL MOTION; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCID MOUSE; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

HUMAN HERPESVIRUS 4;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKINS; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; UP-REGULATION;

EID: 85020903746     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14035     Document Type: Article

References (48)

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. Cancer J. Clin. 64, 9-29 (2014).
2. Xu, Y. et al. Loss of polarity protein AF6 promotes pancreatic cancer metastasis by inducing Snail expression. Nat. Commun. 6, 7184 (2015).
3. Li, D., Xie, K., Wolff, R. & Abbruzzese, J. L. Pancreatic cancer. Lancet (London, England) 363, 1049-1057 (2004).
4. Feldmann, G. et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 67, 2187-2196 (2007).
5. Mekenkamp, L. J. et al. Chromosome 20p11 gains are associated with liverspecific metastasis in patients with colorectal cancer. Gut 62, 94-101 (2013).
6. Glinsky, V. V. et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 63, 3805-3811 (2003).
7. Reymond, N., d'Água, B. B. & Ridley, A. J. Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 13, 858-870 (2013).
8. Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252 (2009).
9. Chaturvedi, V., Collison, L. W., Guy, C. S., Workman, C. J. & Vignali, D. A. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J. Immunol. 186, 6661-6666 (2011).
10. Collison, L. W. et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101 (2010).
11. Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007).
12. Olson, B. M., Sullivan, J. A. & Burlingham, W. J. Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. Front. Immunol. 4, 315 (2013).
13. Collison, L. W. et al. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290-299 (2012).
14. Niedobitek, G., Päzolt, D., Teichmann, M. & Devergne, O. Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J. Pathol. 198, 310-316 (2002).
15. Nishino, R. et al. Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin. Cancer Res. 17, 6272-6286 (2011).
16. Pylayeva-Gupta, Y. et al. IL35-producing B cells promote the development of pancreatic neoplasia. Cancer Discov. 6, 247-255 (2016).
17. Mi, H. et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 33, D284-D288 (2005).
18. Millan, J. et al. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat. Cell Biol. 8, 113-123 (2006).
19. Kanters, E. et al. Filamin B mediates ICAM-1-driven leukocyte transendothelial migration. J. Biol. Chem. 283, 31830-31839 (2008).
20. Yang, L. et al. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-a-activated vascular endothelium under flow. Blood 106, 584-592 (2005).
21. Languino, L. R. et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73, 1423-1434 (1993).
22. Ehret, G. B. et al. DNA binding specificity of different STAT proteins: comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276, 6675-6688 (2001).
23. Whiteside, T. The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904-5912 (2008).
24. Mocellin, S. & Nitti, D. TNF and cancer: the two sides of the coin. Front. Biosci. 13, 2774-2783 (2007).
25. Massagué, J. TGFb in cancer. Cell 134, 215-230 (2008).
26. Gastl, G. A. et al. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55, 96-101 (1993).
27. Bellone, G. et al. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J. Immunol. 177, 3448-3460 (2006).
28. Wang, Z. et al. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J. Immunol. 190, 2415-2423 (2013).
29. Nicholl, M. B. et al. Il-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: Evidence for a role as an autocrine growth factor. Cytokine 70, 126-133 (2014).
30. Devergne, O., Coulomb-L'Herminé, A., Capel, F., Moussa, M. & Capron, F. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am. J. Pathol. 159, 1763-1776 (2001).
31. Chiyo, M. et al. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int. J. Cancer 115, 437-442 (2005).
32. Heckel, M. C. et al. Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70. Cell. Immunol. 266, 143-153 (2011).
33. Spicer, J. D. et al. Neutrophils promote liver metastasis via mac-1-Mediated interactions with circulating tumor cells. Cancer Res. 72, 3919-3927 (2012).
34. Gorina, R., Lyck, R., Vestweber, D. & Engelhardt, B. b2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier. J. Immunol. 192, 324-337 (2014).
35. Armstrong, P. C. et al. Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction. Blood 126, e11-e18 (2015).
36. Hong, Y. K. et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225, 351-357 (2002).
37. Johnson, L. A. et al. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203, 2763-2777 (2006).
38. Yuan, M.-L. et al. Regulation of CD4+ T cells by pleural mesothelial cells via adhesion molecule-dependent mechanisms in tuberculous pleurisy. PLoS ONE 8, e74624 (2013).
39. Djafarzadeh, R. et al. Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells. PLoS ONE 7, e33963 (2012).
40. Sumagin, R., Lomakina, E. & Sarelius, I. H. Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. Am. J. Physiol. Heart Circ. Physiol. 295, H969-H977 (2008).
41. Etienne-Manneville, S. ICAM-1-coupled signaling pathways in astrocytes converge to cyclic AMP response element-binding protein phosphorylation and TNF-alpha secretion. J. Immunol. 163, 668-674 (1999).
42. Liou, G.-Y. et al. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. Cancer Discov. 5, 52-63 (2015).
43. Fujisawa, T., Joshi, B., Nakajima, A. & Puri, R. K. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Cancer Res. 69, 8678-8685 (2009).
44. Zhao, T. et al. LASP1 is a HIF1alpha target gene critical for metastasis of pancreatic cancer. Cancer Res. 75, 111-119 (2015).
45. Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323 (2007).
46. Pronk, A., Leguit, P., Hagelen, E., Vroonhoven, T. J. M. V. V. & Verbrugh, H. A. A cobblestone cell isolated from the human omentum: the mesothelial cell; isolation, identification, and growth characteristics. Vitro Cell. Dev. Biol. 29A, 127-134 (1993).
47. Lawrence, M. B., Mcintire, L. V. & Eskin, S. G. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood 70, 1284-1290 (1987).
48. Mendonsa, A. M. et al. Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver. Mol. Cancer 14, 49 (2015).